Mariliina Arjama

Colorectal Cancer Consensus Molecular Subtypes Translated to Preclinical Models Uncover Potentially Targetable Cancer Cell Dependencies

Anita Sveen, Jarle Bruun, Peter W. Eide et al. · Clinical Cancer Research · 2017 · 245 citations · Full text

Glucocorticoids induce differentiation and chemoresistance in ovarian cancer by promoting ROR1-mediated stemness

Hanna Karvonen, Mariliina Arjama, Laura Kaleva et al. · Cell Death and Disease · 2020 · 63 citations · Full text

Membrane-Type-3 Matrix Metalloproteinase (MT3-MMP) Functions as a Matrix Composition-Dependent Effector of Melanoma Cell Invasion

Olga Tatti, Mariliina Arjama, Annamari Ranki et al. · PLoS ONE · 2011 · 49 citations · Full text

Melanoma Cell Invasion, Cancer Biology, Membrane-type-3 Matrix Metalloproteinase +17

Evaluating Targeted Therapies in Ovarian Cancer Metabolism: Novel Role for PCSK9 and Second Generation mTOR Inhibitors

Dafne Jacome Sanz, Juuli Raivola, Hanna Karvonen et al. · Cancers · 2021 · 29 citations · Full text

Drug response profiles in patient-derived cancer cells across histological subtypes of ovarian cancer: real-time therapy tailoring for a patient with low-grade serous carcinoma

Astrid Murumägi, Daniela Ungureanu, Suleiman A. Khan et al. · British Journal of Cancer · 2022 · 24 citations · Full text